Importance of metabolites in antiarrhythmic therapy
- 22 September 1983
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (6) , C3-C7
- https://doi.org/10.1016/0002-9149(83)90625-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.Journal of Clinical Investigation, 1984
- Electrophysiologic effects of N-acetylprocainamide in human beingsThe American Journal of Cardiology, 1981
- Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamideThe American Journal of Cardiology, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Antibodies to Nuclear Antigens in Patients Treated with Procainamide or AcetylprocainamideNew England Journal of Medicine, 1979
- Evidence for the biotransformation of procainamide to a reactive metaboliteToxicology and Applied Pharmacology, 1979
- Remission of Procainamide-Induced Lupus Erythematosus with N-Acetylprocainamide TherapyAnnals of Internal Medicine, 1979
- Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drugEuropean Journal of Clinical Pharmacology, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Cumulation of N‐acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal functionClinical Pharmacology & Therapeutics, 1977